D'ALIBERTI DEBORAH

Castoldi, G., Mauri, M., D’Aliberti, D., Spinelli, S., Testa, L., Gaverina, F., et al. (2025). Transcriptomic Profile of Human Osteoblast-like Cells Grown on Trabecular Titanium. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(8) [10.3390/ijms26083598]. Detail

Fontana, D., Crespiatico, I., Zaghi, M., Mastini, C., D’Aliberti, D., Mauri, M., et al. (2024). First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis. Intervento presentato a: Forum nazionale sulla Medicina di Precisione. Il Modello HEAL ITALIA e il contributo della Ricerca al Sistema Sanitario del Futuro, Palermo, Italia. Detail

Villa, M., Geeta, G., Malighetti, F., Mauri, M., Arosio, G., Cordani, N., et al. (2024). Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma. BRITISH JOURNAL OF CANCER, 131(11), 1781-1795 [10.1038/s41416-024-02881-7]. Detail

Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail

Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD, 143(14), 1399-1413 [10.1182/blood.2023021349]. Detail